0.4800USD+6.43%Mkt Cap: 9.27M USDP/E: —Last update: 2026-05-26
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products …
Industry Peers
Health Information Services25.85BUSDP/E 29.1
11.66BUSDP/E 78.1
8.39BUSD—
7.49BSEKP/E 33.5
7.35BUSDP/E 35.7
5.05BTRYP/E 27.0
4.13BUSD—
3.79BUSDP/E 29.5
Indicators:|
Key Statistics
Company
Market Cap9.27M USD
Enterprise Value6.07M USD
Revenue (TTM)456.02K USD
Gross Profit250.39K USD
Net Income (TTM)-20.64M USD
Revenue/Share0.0450 USD
Last Price0.4800 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees3
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.38
EV/Revenue13.30
P/S16.49
P/B0.46
EPS (TTM)-1.27
EPS (Forward)—
52W Range
0.162012% of range2.750
52W High2.750 USD
52W Low0.1620 USD
Profitability
Gross Margin54.91%
Oper. Margin-1576.40%
EBITDA Margin0.00%
Profit Margin-4526.76%
ROE-135.80%
ROA-128.30%
Growth
Revenue Growth-10.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.85M USD
CapEx (TTM)—
FCF Margin411.48%
FCF Yield20.24%
Net Debt-1.18M USD
Net Debt/EBITDA0.07
Balance Sheet
Debt/Equity0.02
Current Ratio1.74
Quick Ratio1.67
Book Value/Sh0.9570 USD
Cash/Share0.0880 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateOct 16, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.17.17M
Float13.23M
Insiders10.04%
Institutions4.81%
Short Interest
Short Ratio0.6d
Short % Float2.96%
Short % Out.2.66%
Shares Short451.46K
Short (prev mo.)1.02M
Technical
SMA 500.3804 (+26.2%)
SMA 2001.130 (-57.5%)
Beta2.12
S&P 52W Chg28.31%
Avg Vol (30d)739.52K
Avg Vol (10d)955.44K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—